Peroxochromium(IV) complexes are putative DNA-damaging and mutagenic agents in chromium(VI)-mediated carcinogenesis. The reaction between aquaethylenediaminebis(peroxo)chromium(IV) and glutathione at neutral pH exhibits a cyclic redox process displaying a persistent recycling of Cr(IV) and Cr(VI) with the intervention of chromium(V) intermediates. The coordination by a glutathione molecule triggers an autooxidation of the Cr(IV)-peroxo complex to Cr(VI) via an internal electron-transfer process followed by reduction to Cr(IV) via metastable chromium(V) intermediates. The cycle is repeated by the second peroxo species. The Cr(V) and -(IV) intermediates have been characterized as mono- and bisglutathionato complexes with or without a coordinated peroxo moiety. These intermediates are capable of damaging DNA, as evidenced by single strand breaks and DNA oxidation. The implication here is that the potential for a persistent, if not perpetual, deadly chromium carcinogenic cycle exists in the cellular milieu through the assistance of molecular oxygen and glutathione.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/ja102173v | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
EPR and DFT analysis of biologically relevant chromium(V) complexes with d-glucitol and d-glucose.
J Inorg Biochem
September 2016
University of Antwerp, Department of Physics, Universiteitsplein 1, B-2610 Antwerp, Belgium; Universidad National de Rosario, Departamento de Químico Física - Área Química General, Facultad de Ciencias Bioquímicas y Farmacéuticas, IQUIR-CONICET, Suipacha 531, Rosario, Santa Fe, Argentina. Electronic address:
1,2-diolato ligands, such as carbohydrates and glycoproteins, tend to stabilize chromium(V), thus forming important intermediates that have been implicated in the genotoxicity of Cr(VI). Since many years, room-temperature continuous-wave electron paramagnetic resonance (EPR) at X-band microwave frequencies has been used as a standard characterization tool to study chromium(V) intermediates formed during the reduction of Cr(VI) in the presence of biomolecules. In this work, the added value is tested of using a combination of pulsed and high-field EPR techniques with density functional theory computations to unravel the nature of Cr(V) complexes with biologically relevant chelators, such as carbohydrates.
View Article and Find Full Text PDFSpectroscopic characterization of genotoxic chromium(V) peptide complexes: Oxidation of Chromium(III) triglycine, tetraglycine and pentaglycine complexes.
J Inorg Biochem
September 2016
School of Chemistry, The University of Sydney, NSW 2006, Australia. Electronic address:
Evidence is growing that metabolites of Cr(III) dietary supplements are partially oxidized to carcinogenic Cr(VI) and Cr(V) in vivo. Hence, we examined oxidations of Cr(III) peptide (triglycine, tetraglycine and pentaglycine) complexes to Cr(VI) and Cr(V) by PbO at 37°C and physiological pH values between 3.85 and 7.
View Article and Find Full Text PDFRedox Conversion of Chromium(VI) and Arsenic(III) with the Intermediates of Chromium(V) and Arsenic(IV) via AuPd/CNTs Electrocatalysis in Acid Aqueous Solution.
Environ Sci Technol
August 2015
†Key Laboratory of Drinking Water Science and Technology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.
Simultaneous reduction of Cr(VI) to Cr(III) and oxidation of As(III) to As(V) is a promising pretreatment process for the removal of chromium and arsenic from acid aqueous solution. In this work, the synergistic redox conversion of Cr(VI) and As(III) was efficiently achieved in a three-dimensional electrocatalytic reactor with synthesized AuPd/CNTs particles as electrocatalysts. The AuPd/CNTs facilitated the exposure of active Pd{111} facets and possessed an approximate two-electron-transfer pathway of oxygen reduction with the highly efficient formation of H2O2 as end product, resulting in the electrocatalytic reduction of 97.
View Article and Find Full Text PDFIsolation, characterization, and nuclease activity of biologically relevant chromium(V) complexes with monosaccharides and model diols. Likely intermediates in chromium-induced cancers.
Inorg Chem
April 2013
Fachbereich Chemie, Philipps-Universität Marburg, Hans-Meerwein-Strasse, D-35032 Marburg, Germany.
The stabilization of Cr(V) by biological 1,2-diolato ligands, including carbohydrates, glycoproteins, and sialic acid derivatives, is likely to play a crucial role in the genotoxicity of Cr(VI) and has also been implicated in the antidiabetic effect of Cr(III). Previously, such complexes have been observed by electron paramagnetic resonance (EPR) spectroscopy in living cells or animals, treated with carcinogenic Cr(VI), as well as in numerous model systems, but attempts to isolate them have been elusive. Recently, the first crystal structure of a Cr(V) complex with cis-1,2-cyclohexanediol (1, a close structural analogue of carbohydrates) has been reported.
View Article and Find Full Text PDFSynthesis and characterization of a chromium(V) cis-1,2-cyclohexanediolato complex: a model of reactive intermediates in chromium-induced cancers.
Inorg Chem
November 2012
Fachbereich Chemie, Philipps-Universität Marburg, Hans-Meerwein Strasse, D-35032 Marburg, Germany.
Stabilization of chromium(V) by biological 1,2-diolato ligands, e.g., carbohydrates and glycoproteins, is postulated to be crucial for both the chromium(VI)-induced carcinogenicity and chromium(III) antidiabetic activities.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!